Sun Pharmaceutical Industries informs about press release

28 Jul 2016 Evaluate

Sun Pharmaceutical Industries has informed about a Press Release dated July 27, 2016 titled ‘Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis.’

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1736.85 6.90 (0.40%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1736.85
Dr. Reddys Lab 1215.65
Cipla 1466.05
Zydus Lifesciences 895.00
Lupin 2189.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×